Medisorb presented its products at CPhI Middle East&Africa 2019
The international specialized exhibition of the pharmaceutical industry was held in Abu Dhabi (UAE).
«Medisorb» company, the leader of Perm Industrial Pharmaceutical Cluster, visited the largest international exhibition CPhI Middle East & Africa 2019 in order to promote its products in the regions of the Middle East and Africa, as well as to search for new distributors.
On a scale of pharmaceutical business, Medisorb is not a very large enterprise, therefore, for the initial stages of international promotion, it selects the most interesting, promising and attended events.
The Perm pharmaceutical manufacturer presented the inhalation anesthetic «Sevoflurane», the cardiological product «Ivabradin Medisorb» which is in high demand on the international market, the «Razagilin Medisorb» — drug for treatment of Parkinson’s disease, «Cinacalcet Medisorb» — the product for some types of oncology and parathyroid glands impairment, and other products which are of immediate interest in this region.
The bright stand of Medisorb attracted a lot of attention. It was visited by a member of the ruling family of the emirate of Abu Dhabi, His Highness Sheikh Nahyan bin Mubarak al Nahyan.
«The United Arab Emirates and, in particular, Abu Dhabi, is a center of attraction for the Middle East and African regions and even European states. The place is ideal for the first steps to enter wide international markets. Participation allowed us to get about 130 new promising contacts of partners from the UAE, Saudi Arabia, South Africa, Sudan, Jordan and other countries, as well as to significantly introduce the company’s brand in the new market»
Besides, in Abu Dhabi, Medisorb continued to communicate with potential distributors, the contacts with whom were established during CPhI South East Asia held in Thailand in the spring of 2019.